author-photo

Mariel C. Paul

Medical University of Vienna

6

Papers

78

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

EPHA2 Is a Predictive Biomarker of Resistance and a Potential Therapeutic Target for Improving Antiepidermal Growth Factor Receptor Therapy in Colorectal Cancer

2019 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (23)
PD-019Optimizing treatment with anti-epidermal growth factor receptor drugs for patients with metastatic colorectal cancer: novel mechanisms of resistance beyond RAS

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
96PAXL has a prognostic role in metastatic colorectal cancer (mCRC) and is a predictive biomarker of lack of efficacy of chemotherapy (CT) + cetuximab in RAS wild type (WT) patients (pts)

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (2)
1637PEph A2 expression is a predictive biomarker of poorer activity and efficacy of FOLFIRI + cetuximab in RAS WT metastatic colorectal cancer (mCRC) patients (pts) in the CAPRI GOIM trial

2017 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients

2017 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (52)
Generation of an 870 kb deletion encompassing the Skt/Etl4 locus by combination of inter- and intra-chromosomal recombination

2015 BMC Genetics
Show All
- Source
- Cite
- Save
Citations (1)